With the second wave of COVID-19 here, India’s preparedness is in question. We’re a vaccine manufacturing powerhouse but we suffer from a severe vaccine shortage. This has been compounded by a shortage of Remdesivir, the injectable anti-viral repurposed to treat COVID-19.
It’s a double whammy that has implications not just for public health but for the economy too.
Learn more about your ad choices. Visit megaphone.fm/adchoices